Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-25 18:00 CEST (UTC+2h)

Power in the pivotal study (EU) [Power / Sample Size]

posted by valivetiananth - India, 2018-05-31 13:49  - Posting: # 18832
Views: 1,247

Dear All,

Greetings!!!

We have conducted a pivotal study for Europe with 48 subjects considering ~80% power, ISCV: 23%. The study was bioequivalent and 90% CI is within 80-125 for both Cmax & AUCt.

Power of Cmax and AUCt are 92% & 66% respectively. Kindly guide us how to justify the power less than 80% to HA.


Thanks
Valiveti

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,428 posts in 3,913 threads, 1,176 registered users;
online 26 (0 registered, 26 guests [including 20 identified bots]).

Lack of clarity is always a sign of dishonesty.    Celia Green

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed